Fraser Bocell

Company: Critical Path Institute (C-Path)

Job title: Senior Clinical Outcomes Assessment Scientist

Seminars:

Unpacking FDA’s Response to the Alpha-Synuclein Seed Amplification Assay: What Does This Mean for the Future of Parkinson’s Clinical Trials? 12:00 pm

Showcasing the latest advancements of αSyn-SAA in monitoring drug-induced improvement in PD progression Highlighting opportunities unlocked by αSyn-SAA to establish objective endpoints and monitor efficacy of PD drugsRead more

day: Conference Day Two - Track Three